Vimarsana
Biggest News Aggregation in the World

Page 2 - Transition Report News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Transition Report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Transition Report Today - Breaking & Trending Today

Perspective Therapeutics Introduces "Pre-Targeting" Theranostic Technology Platform - Vimarsana News

Perspective Therapeutics Introduces "Pre-Targeting" Theranostic Technology Platform

Signs a World-Wide Exclusive License with Stony Brook University for a Novel Platform that can Enhance Radionuclide TargetingReceives up to $2.4M ...

Bristow Enters Into New Long-term Equipment Financing for up to £55 Million - Vimarsana News

Bristow Enters Into New Long-term Equipment Financing for up to £55 Million

HOUSTON, Jan. 24, 2024 /PRNewswire/ -- Bristow Group Inc. and its subsidiaries announced today that it has entered into a new twelve-year secured equipment financing for an aggregate amount up to...

Perspective Therapeutics Announces Proposed Public Offering - Vimarsana News

Perspective Therapeutics Announces Proposed Public Offering

SEATTLE, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01 -January 17, 2024 at 08:03 am EST - Vimarsana News

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01 -January 17, 2024 at 08:03 am EST

SEATTLE, Jan. 17, 2024 -- Perspective Therapeutics, Inc. , today announced that it began patient recruitment for the second dosing cohorts in clinical studies for both of its lead product...

Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing Capability - Vimarsana News

Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing Capability

Lantheus will have the option to negotiate an exclusive license to Perspective Therapeutics’ Pb212-VMT-α-NETLantheus will have the option to co-fund and negotiate an exclusive license for certain...